Thank you, Mr. Chair.
Welcome, Madam Stoddart. It's good to see you back here.
I too am returning to this committee from the last session, but I recall we had fairly considerable discussions at the committee in the last Parliament in respect to the review of PIPEDA. I notice in your RPP that you have been given considerable funding or, in the words of the report, “approval to stabilize funding for PIPEDA”.
I wonder if you could give us an update on what in fact that translates to. What sort of changes in activities have taken place to stabilize that and to put in place the resources to respond to the demands of PIPEDA across your organization?